- Capital Cube•2 months ago
Click here to see latest analysisGenVec, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of GenVec, Inc. – Emergent BioSolutions Inc., Pfizer Inc., Novavax, Inc., Novartis AG Sponsored ADR, Merck & Co., Inc., Sangamo BioSciences, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson and […] (Read more...) The post GenVec, Inc. :GNVC-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.
- TheStreet.com•3 months ago
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits
|Ask||1.00 x 6000|
|52wk Range||0.35 - 3.69|
|Day's Range||0.59 - 0.62|
|Avg Vol (3m)||131,823|
As of 4:00 PM EDT. Market closed.